| 摘要 |
The present invention relates to a pharmaceutical formulation comprising tapentadol and cyclodextrin. The invention further relates to a process for producing said pharmaceutical formulations. Finally, the invention relates to the use of cyclodextrin for producing a tapentadol-containing pharmaceutical formulation, wherein the pharmaceutical formulation has a dissolution of at least 0% after 15 min. |
